Cost-Effectiveness of Saxagliptin in Type 2 Diabetes in the United States

被引：0
|
作者：
Bergenheim, Klas
Williams, Setareh A.
Bergeson, Joette G.
Stern, Lee
Sriprasert, Michelle
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2369-PO
引用
收藏
页码：A629 / A630
页数：2
相关论文
共 50 条
  • [21] The Cost-Effectiveness of Supplemental Carnosine in Type 2 Diabetes
    Menon, Kirthi
    de Courten, Barbora
    Magliano, Dianna J.
    Ademi, Zanfina
    Liew, Danny
    Zomer, Ella
    NUTRIENTS, 2022, 14 (01)
  • [22] Cost-effectiveness of primary prevention of type 2 diabetes
    Icks, A.
    Chernyak, N.
    Klein, A.
    Brinks, R.
    Genz, J.
    Giani, G.
    DIABETOLOGE, 2011, 7 (02): : 92 - 98
  • [23] COST-EFFECTIVENESS OF EXERCISE PROGRAMS IN TYPE 2 DIABETES
    Coyle, Doug
    Coyle, Kathryn
    Kenny, Glen P.
    Boule, Normand G.
    Wells, George A.
    Fortier, Michelle
    Reid, Robert D.
    Phillips, Penny
    Sigal, Ronald J.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (03) : 228 - 234
  • [24] Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States
    Kamble, Shital
    Schulman, Kevin A.
    Reed, Shelby D.
    VALUE IN HEALTH, 2012, 15 (05) : 632 - 638
  • [25] Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review
    Bosetti, Rita
    Tabatabai, Laila
    Naufal, Georges
    Menser, Terri
    Kash, Bita
    PLOS ONE, 2021, 16 (11):
  • [26] Cost-effectiveness analysis in the United States - Reply
    Pearson, SD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (23): : 2722 - 2723
  • [27] Update on the cost-effectiveness of contraceptives in the United States
    Trussell, James
    Sinai, Irit
    CONTRACEPTION, 2010, 82 (04) : 391 - 392
  • [28] Cost-Effectiveness of Hormone Therapy in the United States
    Lekander, Ingrid
    Borgstrom, Fredrik
    Strom, Oskar
    Zethraeus, Niklas
    Kanis, John A.
    JOURNAL OF WOMENS HEALTH, 2009, 18 (10) : 1669 - 1677
  • [29] A COST-EFFECTIVENESS ANALYSIS OF ALOGLIPTIN IN COMPARISON TO SAXAGLIPTIN
    Wingate, L. T.
    Oishi, T. S.
    Ali, Shubar N. S.
    VALUE IN HEALTH, 2015, 18 (03) : A61 - A61
  • [30] COST-EFFECTIVENESS ANALYSIS OF METFORMIN COMBINED WITH SAXAGLIPTIN VERSUS METFORMIN COMBINED WITH SULFONYLUREAS IN TYPE-2 DIABETES PATIENTS IN CHILE
    Elgart, J.
    Caporale, J.
    Aiello, E. C.
    Waschbusch, M.
    Jotimliansky, L.
    Gagliardino, J. J.
    Valencia, J. E.
    VALUE IN HEALTH, 2011, 14 (03) : A96 - A96
12345